berberine has been researched along with Edema, Pulmonary in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Histopathological changes, such as pulmonary edema, infiltration of inflammatory cells and coagulation, were also attenuated by THBru." | 1.43 | Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways. ( Chen, L; Ge, H; Kou, J; Liu, H; Yu, B; Yu, S; Yu, X; Zhang, J; Zhang, Y, 2016) |
| "Acute lung injury is still a significant clinical problem having a high mortality rate despite significant advances in antimicrobial therapy and supportive care made in the past few years." | 1.35 | Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. ( Fu, YM; Lu, DX; Qi, RB; Wang, HD; Wang, YP; Yan, YX; Zhang, HQ, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, K | 1 |
| Liu, S | 1 |
| Shen, Y | 1 |
| Li, Q | 1 |
| Yu, X | 1 |
| Yu, S | 1 |
| Chen, L | 1 |
| Liu, H | 1 |
| Zhang, J | 1 |
| Ge, H | 1 |
| Zhang, Y | 1 |
| Yu, B | 1 |
| Kou, J | 1 |
| Zhang, HQ | 1 |
| Wang, HD | 1 |
| Lu, DX | 1 |
| Qi, RB | 1 |
| Wang, YP | 1 |
| Yan, YX | 1 |
| Fu, YM | 1 |
3 other studies available for berberine and Edema, Pulmonary
| Article | Year |
|---|---|
Berberine attenuates cigarette smoke-induced acute lung inflammation.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Berberine; Bronchoalveolar Lavage Fluid; Chemo | 2013 |
Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-κB signaling pathways.
Topics: Acute Lung Injury; Animals; Berberine; Blotting, Western; Bronchoalveolar Lavage Fluid; Cell Count; | 2016 |
Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice.
Topics: Animals; Berberine; Bronchoalveolar Lavage Fluid; Lipopolysaccharides; Lung Injury; Mice; Neutrophil | 2008 |